Interestingly, circulating tumor cells (CTCs) from patients with pancreatic cancer (PAC) showed higher levels of ROR1 and greater proliferative and invasive potential compared to cells from non-cancerous tissues and the PAC cell lines, PANC-1 and SW-1990. This evidence concerns the gene ROR1 and gonorrhea.